Rare disease hope: drug tofacitinib tested for blau syndrome
NCT ID NCT06688838
First seen Jan 29, 2026 · Last updated May 20, 2026 · Updated 15 times
Summary
This study looks at how well the drug tofacitinib works for people with Blau syndrome, a rare genetic disease that causes joint, eye, and skin problems. Researchers will review medical records of 24 patients to see who responds best and why. The goal is to better control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLAU SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yikai YU
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.